0.0721EUR0.00%Mkt Cap: 5.03M EURP/E: —Last update: 2026-05-29
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonym…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap5.03M EUR
Enterprise Value7.36M EUR
Revenue (TTM)10 EUR
Gross Profit-1.15M EUR
Net Income (TTM)-8.89M EUR
Revenue/Share0.0000 EUR
Last Price0.0721 EUR
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees1
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0011648971
Valuation
P/E (Trailing)—
P/E (Forward)-0.19
PEG—
EV/EBITDA-5.00
EV/Revenue735674.30
P/S502608.70
P/B-2.06
EPS (TTM)-0.80
EPS (Forward)-0.37
52W Range
—
52W High0.0721 EUR
52W Low0.0721 EUR
Profitability
Gross Margin0.00%
Oper. Margin-17545000.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE362.09%
ROA-2507.44%
Growth
Revenue Growth-83.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.21M EUR
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt2.34M EUR
Net Debt/EBITDA-1.59
Balance Sheet
Debt/Equity-1.07
Current Ratio0.37
Quick Ratio0.34
Book Value/Sh-0.0350 EUR
Cash/Share0.0040 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:18
Split DateDec 13, 2013
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.69.71M
Float59.71M
Insiders3.35%
Institutions5.80%
Technical
SMA 500.0721 (-0.0%)
SMA 2000.0721 (-0.0%)
Beta-0.15
S&P 52W Chg27.94%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0721 EUR
BB Middle0.0721 EUR
BB Lower0.0721 EUR
BB Width0.00%
ATR (14)0.0000 EUR
Vol Ratio (20d)—